A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.
Epithelial-mesenchymal transition (EMT) is a crucial pathological event in cancer, particularly in tumor cell budding and metastasis. Therefore, control of EMT can represent a novel therapeutic strategy in cancer. Here, we introduce an innovative three-dimensional (3D) high-throughput screening (HTS...
Main Authors: | Kazuya Arai, Takanori Eguchi, M Mamunur Rahman, Ruriko Sakamoto, Norio Masuda, Tetsuya Nakatsura, Stuart K Calderwood, Ken-Ichi Kozaki, Manabu Itoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5021355?pdf=render |
Similar Items
-
Phenotypic chemical screening using a zebrafish neural crest EMT reporter identifies retinoic acid as an inhibitor of epithelial morphogenesis
by: Laura Jimenez, et al.
Published: (2016-04-01) -
Tumor Budding: The Name is EMT. Partial EMT.
by: Alexandru Dan Grigore, et al.
Published: (2016-04-01) -
High content screening identifies monensin as an EMT-selective cytotoxic compound
by: Marion Vanneste, et al.
Published: (2019-02-01) -
Screening therapeutic EMT blocking agents in a three-dimensional microenvironment
by: Aref, Amir R., et al.
Published: (2014) -
Efficacy of the CDK7 Inhibitor on EMT-Associated Resistance to 3rd Generation EGFR-TKIs in Non-Small Cell Lung Cancer Cell Lines
by: Wonjun Ji, et al.
Published: (2020-12-01)